Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals, has been seeing strong growth momentum ...

So far, BSX stock has risen 19% year-to-date. Separately, CROX reports earnings tomorrow. Will the stock pop on the news? See ...

StockNews.com downgraded shares of Boston Scientific (NYSE:BSX – Free Report) from a buy rating to a hold rating in a research note issued to investors on Thursday. Other analysts have also issued ...

Nations Financial Group Inc. IA ADV trimmed its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 5.9% in the ...

From robotic surgery to smart diagnostics, the medical devices industry is transforming healthcare delivery. To capitalize on this trend, you might consider adding Boston Scientific Corp (BSX), Becton ...

Argus Research analyst David Toung maintained a Buy rating on Boston Scientific (BSX – Research Report) on February 14. The company’s shares ...

Boston Scientific Corp. grew its headcount by 5,000 and its real estate footprint by more than 1 million square feet in 2024.

The favorable estimate revisions indicate brokers’ confidence in the stock. As of Feb. 20, 2025, Boston Scientific's stock is trading at $105.67, reflecting a year-to-date increase of 18.9%.